Data I/O Reports 2014 Fourth Quarter Results
Return to Full-Year Profitability on 17% Revenue Growth and New Product Momentum
UniPixel Reports Fourth Quarter 2014 Results
Company Sees Commercial Shipments of Diamond Guard and InTouch Sensors –Powered by Kodak– in Q2
Cypress–s New $10 PSoC 5LP Prototyping Kit Gives Designers Access to Unmatched Processing Power in a One-Chip Solution
Easy-to-Use Prototyping Board Accelerates Time-to-Production, While Reducing System Costs With the Highly-Integrated ARM(R) Cortex(R)-M3-Based PSoC(R) 5LP Solution
eSilicon Promotes Ajay Lalwani to Vice President, Global Manufacturing Operations
Semiconductor Industry Veteran Facilitates Company Growth
Test automation hand in hand: imbus now Ranorex GOLD Partner
Moehrendorf, 26 February 2015 – It’s the enthusiasm for efficient test automation, which motivates imbus and Ranorex. Both companies employ their strengths in order to provide solutions tailored to meet the individual needs of customers. That is why imbus has been awarded the status as GOLD Partner by Ranorex.
New EEMBC(R) CoreMark(R)-Pro Benchmark Bumps Processor Benchmarking Capabilities
Builds on Major Success and Popularity of EEMBC CoreMark
Aircraft Fuel Flow Instruments
Aircraft Fuel Flow (FF) is probably one of the most important of aircraft engine parameters that need to be captured.
Cascade Microtech Welcomes Lake Shore Cryotronics as New Collaboration Partner to Support Broad Customer Requirements
MeasureOne(TM) Program Offers Customers Best-of-Breed Choices for Probing in Cryogenic and High-Flux Magnetic Environments
Major Energy Inks Deal With the New York Yankees on New Multi-Year Marketing Partnership
Major Energy Becomes the Official Energy Supply Company of the New York Yankees
Cell MedX Corp. (CMXC) Announces Results of Preliminary Analysis of Metabolomic Assays in Phase 1 Pilot Clinical Trial
LAS VEGAS, NV — (Marketwired) — 02/25/15 — Cell MedX Corp. (OTCQB: CMXC) (the "Company") is pleased to announce that it has received the first results of the analysis of metabolomic assays taken during the Phase 1 pilot clinical trial.The pilot clinical discovery phase trial in two diabetic subjects was performed in January 2015. Its main objective was to examine the short term metabolic impact of a single treatment with e-balance technology. Additional assays are pending. Analysis